Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: kolo55 who wrote (3983)	8/8/2000 10:49:42 AM
From: BostonView	Respond to of 4140

Tidy pile of shares, Paul. I hope you took them out of street name. SNRS could use a little follow-through action today... BV

To: kolo55 who wrote (3983)	8/8/2000 11:43:16 AM
From: Bridge Player	Read Replies (2) \| Respond to of 4140

<<Lehman expected $30M in revenues this year, and $80M next year... I think Sunrise will blow both numbers away. And since enough of the revenues will be coming from the $200 per eye royalty, a lot of the money will go to the bottom line. A year from now, it wouldn't surprise me to see this company on target to earn over a dollar per share for 2001>> Hmmm...There are around 47 million shares outstanding. At $1/share earnings (I presume you mean after-tax, bottom line earnings), thats 47 million earnings. On 100 million in revenues, 47% net after tax. On 120 million, 40% net after tax. Just wondering what your actual expectations are for 2001 sales, profit margins, and earnings? BP